Global Synthetic Peptides Market: Overview

Peptides are mainly made up of amino acid chains which are linked with each other with the peptide bond. For instance, dipeptides are formed by two amino acids, whereas tripeptides are made up of three amino acids. Polypeptides are an unbranched chain of amino acids which are joined by multiple peptide bonds. A chain which constitute 50 residues of amino acids are called peptides. On the other hand, an amino acid chain consisting more than 50 amino acids is known as proteins. Such peptides are mostly used as a therapeutic agent for treating various diseases condition. This is because of the peptides’ performability in various metabolic function in humans’ body. Synthetic peptides are a type of peptide which are mainly produced artificially – outside the cell through chemical reactions. These peptides are extensively used for various research purposes in several biotechnological and pharmaceutical companies. Such USPs are driving the global synthetic peptides market.

The global synthetic peptides market is mainly segmented on the basis of route of administration, application, distribution channel, marketing status and region. Under application, cardiovascular, oncology, hematological disorders, metabolic disorders, gastrointestinal disorders, dermatology, respiratory disorders, and others are the prominent segments comprising the market. Whereas, with respect to route of administration, key segments present in the global synthetic peptides market are parenteral and oral. In terms of distribution channel, the synthetic peptides market is segmented into retail pharmacies, hospital pharmacies, drug stores, online pharmacies, and others. Based on marketing status, the market is bifurcated into generics and branded.

Global Synthetic Peptides Market: Key Trends

Artificial peptide synthesis highly influences the production of a wide range of antibodies. Such artificial synthesis helps in inventing unique therapeutic techniques which are highly used for drug discovery, biological research, and product development. All such factors are fueling growth in the global synthetic peptides market. Various companies in the market are maintaining peptide libraries which further help in developing various types of vaccines, amino acid sequencing for research activities and drug screening. All these advantages are propelling expansion in the global synthetic peptides market.

Furthermore, rising demand for research and development for early detection and diagnosis of diseases, and growing prevalence of various metabolic disorders and cardiovascular disease are fueling demand in the global synthetic peptides market. Along with this, increasing healthcare expenditures and rising number of clinical trials using synthetic peptides, and rapid advancements in synthetic peptides for producing vaccines due to excellent specific are also boosting the global synthetic peptides market. Some other factors fueling growth in the global synthetic peptides market includes rapid technological advancements in the treatment and diagnostic process, mainly for infectious diseases and molecular techniques advancement.

Global Synthetic Peptides Market: Regional Outlook

With respect to geography, North America is leading the global synthetic peptides market as the region has witnessed rapid technological advancements in medicine field. Rising healthcare infrastructure, increasing prevalence of lifestyle diseases, and high drugs pricing are also responsible for fueling synthetic peptides market in this region. However, increasing number of multi-specialty hospitals and clinics and rising disposable incomes for expanding healthcare availability in Asia Pacific makes this region exhibit a substantially fast growth.

Global Synthetic Peptides Market: Competitive Landscape

Some of the prominent players operating in the global synthetic peptides market are Bachem Holding AG, Thermo Fisher Scientific, Teva Pharmaceutical Industries Ltd., and Novo Nordisk A/S. Each of these companies has been broadly described in the report in terms of prime strategies, revenue gained in recent times, and growth projected to attain in forthcoming years, in terms of market shares.

Leading segments of the global synthetic peptides market:


  • Oncology
  • Cardiovascular
  • Metabolic Disorders
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Dermatology
  • Others

Route of administration

  • Parenteral
  • Oral

Marketing status

  • Branded
  • Generics

Distribution channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Others

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Synthetic Peptides Market

Pre Book